The Patent Finder

MaBel GmbH

Also on record
Records under this name other than patents MaBel GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to MaBel GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,610,292Uses for 4,17β-dihydroxyandrost-4-ene-3-one
Formerly held
Lapsed on the fee record
Ended Apr 4, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 4, 2025USPTO record
US 9,138,477Uses for 4,17β-dihydroxyandrost-4-ene-3-one
Formerly held
Lapsed on the fee record
Ended Sep 22, 2023 · USPTO record
Lapsed on the fee recordEnded Sep 22, 2023USPTO record
US 9,114,163Medication against breast cancer and related diseases
Formerly held
Lapsed on the fee record
Ended Aug 25, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 25, 2023USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited